Phenytoin

on 27.1.07 with 0 comments



  • Overview

    • Effective in suppression of ventricular arrhythmias associated with digitalis toxicity

    • Less effective than quinidine, procainamide, or lidocaine, in treatment of ventricular arrhythmias due to other etiologies

  • Pharmacokinetics:

    • Routes of administration: oral, or IV

    • Normal saline preferred -- phenytoin may precipitate in 5% dextrose in water

    • Slow IV injection into large peripheral or central vein preferable-- decreased chance of:

      1. discomfort

      2. thrombosis at injection site

    • Hepatic Metabolism --hydroxylation and conjugation (glucuronidation):

      • Elimination half-life: approximately 24 hours

      • Impaired hepatic function may cause excessive phenytoin blood levels

  • Mechanism of Action/Cardiac Effects:

    • Electrophysiological effects on automaticity and conduction velocity--somewhat like lidocaine

    • Shortens QT interval more than any other antiarrhythmic agent

    • No significant effect on ST-T waves or QRS complex

    • No significant myocardial depression

    • Improvement in AV Node Conduction;

    • Depression of SA Nodal Activity

  • Drug-Drug Interaction:

    • Significant SA nodal depression may occur when combining those volatile anesthetics that depress SA nodal activity and phenytoin

    • Drugs that lower phenytoin levels:

      • barbiturates (mechanism:metabolizing enzyme induction)

    • Drugs that increase phenytoin level (inhibit metabolism):

      • warfarin, phenylbutazone, isoniazid

  • Side effect/Toxicities:

    • Primary Toxicity: CNS disturbance (particularly cerebellar-- dose correlated > 18 ug/ml-- exceeding this concentration is unlikely to improve cardiac rhythm)

    • CNS symptoms:

      • ataxia, vertigo, slurred speech, sedation, nystagmus, confusion

    • Partial inhibition of insulin secretion: enhances blood glucose levels in hyperglycemic patients

Stoelting, R.K., "Cardiac Antidysrhythmic Drugs", in Pharmacology and Physiology in Anesthetic Practice, Lippincott-Raven Publishers, 1999, 331-343

Category: Pharmacology Notes

POST COMMENT

0 comments:

Post a Comment